SpletTpl2-IN-34 Tpl2 inhibitor 34;MAP3K8-IN-34 915363-56-3 A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM. supplier price datasheet IC50 chemical structure probechem inhibitor. Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists. SpletThe cytoplasmic protein tumor progression locus 2 (TPL2), also known as cancer Osaka thyroid (Cot), or MAP3K8, is thought to have a significant role in a variety of cancers and illnesses and it...
Interleukin‐1 stimulated activation of the COT catalytic subunit ...
SpletCot/Tpl2/MAP3K8 is a serine/threonine kinase known to activate the ERK, p38, and JNK kinase pathways. Studies of Tpl2 knock-out mice reveal a clear defect in tumor necrosis … SpletThe cytoplasmic protein tumor progression locus 2 (TPL2), also known as cancer Osaka thyroid (Cot), or MAP3K8, is thought to have a significant role in a variety of cancers and … pine trails amphitheater
TPL2 SpringerLink
SpletTpl2 (tumor progression locus 2), also known as COT (cancer osaka thyroid), is a serine/threonine kinase expressed primarily in hematopoietic tissues, lung and liver (1). Over-expression of Tpl2 potentiates MAP kinase pathways through MEK1 and SEK1, as well as through MKK6 and MEK5 (2,3). SpletTPL2/COT/MAP3K8 (TPL2)Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth Joseph H. Jeong1*, Ayesha Bhatia1, Zsolt Toth1, Soohwan Oh1, Kyung-Soo Inn1, Chun-Peng Liao2, Pradip Roy-Burman2, Jonathan Melamed3, Gerhard A. Coetzee4, Jae U. Jung1* 1Department of Molecular Microbiology and Immunology, USC … SpletThe protein kinase COT/Tpl2 is activated by interleukin-1 (IL-1), TNFα and lipopolysaccharide, and its activation by these agonists involves the IκB kinase β (IKKβ) … top of tennessee